Neonatal Rotavirus Vaccine (RV3-BB) Immunogenicity and Safety in a Neonatal and Infant Administration Schedule in Malawi: A Randomized, Double-Blind, Four-Arm Parallel Group Dose-Ranging Study

SSRN Electronic Journal ◽

10.2139/ssrn.3858564 ◽

2021 ◽

Author(s):

Desiree Witte ◽

Amanda Handley ◽

Khuzwayo C. Jere ◽

Nada Bogandovic-Sakran ◽

Ashley Mpakiza ◽

...

Keyword(s):

Rotavirus Vaccine ◽

Double Blind ◽

Administration Schedule ◽

Parallel Group ◽

Dose Ranging

A double-blind, parallel-group, placebo-controlled, dose-ranging, multicenter study of intravenous granisetron in the treatment of postoperative nausea and vomiting in patients undergoing surgery with general anesthesia

Journal of Clinical Anesthesia ◽

10.1016/s0952-8180(97)00190-6 ◽

1997 ◽

Vol 9 (8) ◽

pp. 658-663 ◽

Cited By ~ 25

Author(s):

Ann M. Taylor ◽

Michael Rosen ◽

Pierre A. Diemunsch ◽

Dominique Thorin ◽

Peter L. Houweling

Keyword(s):

General Anesthesia ◽

Multicenter Study ◽

Postoperative Nausea ◽

Postoperative Nausea And Vomiting ◽

Nausea And Vomiting ◽

Double Blind ◽

Parallel Group ◽

Dose Ranging

The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial

Vaccine ◽

10.1016/j.vaccine.2019.09.088 ◽

2020 ◽

Vol 38 (1) ◽

pp. 90-99 ◽

Cited By ~ 3

Author(s):

Benjamin Lee ◽

Dorothy M. Dickson ◽

Masud Alam ◽

Sajia Afreen ◽

Abdul Kader ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Controlled Trial ◽

Rotavirus Vaccine ◽

Double Blind ◽

Randomized Controlled ◽

Parallel Group

Sustained and profound analgesic benefits in people with osteoarthritis of the knee using FX006, an intra-articular extended-release formulation of triamcinolone acetonide: Results from a double-blind, randomized, parallel-group, dose-ranging study

Osteoarthritis and Cartilage ◽

10.1016/j.joca.2016.01.113 ◽

2016 ◽

Vol 24 ◽

pp. S49-S50 ◽

Cited By ~ 1

Author(s):

P.G. Conaghan ◽

S. Cohen ◽

J. Jordan ◽

F. Berenbaum ◽

J. Lufkin ◽

...

Keyword(s):

Triamcinolone Acetonide ◽

Extended Release ◽

Osteoarthritis Of The Knee ◽

Double Blind ◽

Release Formulation ◽

Extended Release Formulation ◽

Parallel Group ◽

Dose Ranging

A twelve-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging, phase II study to assess the clinical efficacy of alosetron (GR68755) in male subjects with irritable bowel syndrome

The American Journal of Gastroenterology ◽

10.1016/s0002-9270(01)03784-4 ◽

2001 ◽

Vol 96 (9) ◽

pp. S317 ◽

Cited By ~ 1

Author(s):

E EDWARDS1

Keyword(s):

Irritable Bowel Syndrome ◽

Phase Ii ◽

Clinical Efficacy ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Dose Ranging ◽

Irritable Bowel ◽

Male Subjects

A multicentre, double-blind, randomised, parallel group, placebo-controlled, dose-ranging pilot study of ethyl-eicosapentaenoate (ethyl-EPA) in patients with schizophrenia

http://isrctn.org/> ◽

10.1186/isrctn44218911 ◽

2012 ◽

Author(s):

Harald Murck

Keyword(s):

Pilot Study ◽

Double Blind ◽

Parallel Group ◽

Dose Ranging

A multicentre, double-blind, randomised, parallel group, placebo-controlled, dose ranging pilot study of ethyl eicosapentaenoate (EPA) as adjunct therapy in patients who remain depressed following treatment with standard antidepressant therapy

http://isrctn.org/> ◽

10.1186/isrctn44366049 ◽

2012 ◽

Author(s):

Harald Murck

Keyword(s):

Pilot Study ◽

Antidepressant Therapy ◽

Double Blind ◽

Adjunct Therapy ◽

Parallel Group ◽

Dose Ranging

Phase II, multicentre, double blind, placebo controlled, parallel group, dose ranging study of ATL-962 (cetilistat) to assess weight loss, safety and tolerability in obese patients with Type II diabetes being treated with metformin, in comparison with orlistat

http://isrctn.org/> ◽

10.1186/isrctn62647464 ◽

2012 ◽

Author(s):

Peter Kopelman

Keyword(s):

Weight Loss ◽

Phase Ii ◽

Type Ii Diabetes ◽

Obese Patients ◽

Type Ii ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Dose Ranging

A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2013.03.021 ◽

2013 ◽

Vol 69 (3) ◽

pp. 416-425.e1 ◽

Cited By ~ 26

Author(s):

Bárður Sigurgeirsson ◽

Koen van Rossem ◽

Steven Malahias ◽

Kerry Raterink

Keyword(s):

Phase Ii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Dose Ranging

A Prospective, Double-Blind, Randomized, Parallel- Group, Dose-Ranging Study of Botulinum Toxin Type A in Female Subjects With Horizontal Forehead Rhytides

Dermatologic Surgery ◽

10.1097/00042728-200305000-00005 ◽

2003 ◽

Vol 29 (5) ◽

pp. 461-467

Author(s):

ALASTAIR CARRUTHERS ◽

JEAN CARRUTHERS ◽

J. COHEN

Keyword(s):

Botulinum Toxin ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Double Blind ◽

Parallel Group ◽

Dose Ranging ◽

Female Subjects

Faculty Opinions recommendation of A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.722859923.793506020 ◽

2015 ◽

Author(s):

Andres Miguel Kanner

Keyword(s):

Partial Seizures ◽

Double Blind ◽

Parallel Group ◽

Dose Ranging